Sodium-Dependent Glucose Transporter Type 2 Inhibitors as a Breakthrough in Neutropenia and Neutrophil Dysfunction Management in Patients with Glycogen Storage Disease Type Ib
Glycogen storage disease type Ib (GSD Ib) is a rare and extremely severe disease included in the group of hereditary carbohydrate metabolism disorders. The condition is caused by pathogenic variants in the SLC37A4 gene leading to glucose metabolic disorder in the liver and kidneys, and as a result t...
Saved in:
| Main Authors: | Andrey N. Surkov, Leyla S. Namazova-Baranova, Anna L. Arakelyan, Evgeny E. Bessonov, Natalia V. Zhurkova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2024-07-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/3521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycogen storage disease type Ib: modern understanding of the pathogenesis of neutropenia and prospects for its treatment with empagliflozin
by: Andrej N. Surkov, et al.
Published: (2023-11-01) -
Glycogen Storage Disease Type Ib: The First Case in Taiwan
by: Hui-Ju Hsiao, et al.
Published: (2009-06-01) -
Empagliflozin as treatment in glycogen storage disease type IB patients
by: María Arbelo Rodríguez, et al.
Published: (2025-06-01) -
Glycogen Storage Disease Type Ib in the Compound Heterozygous State: Case Report
by: Nikol P. Shimkova, et al.
Published: (2025-05-01) -
Molecular characterization of autosomal recessive Glycogen storage disease type Ib in a Pakistani family
by: Zeeshan Nazir, et al.
Published: (2025-03-01)